Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER2 | P43116 | 20/20 | 0.59 |
| ▸ | PTGER4 | P35408 | 19/20 | 0.59 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1083324 | 1.00 | PTGER2 (0.59) | PTGER2PTGER4PTGER3 | |
| SCHEMBL1055319 | 1.00 | PTGER2 (0.59) | PTGER2PTGER4PTGER3 | |
| SCHEMBL1057878 | 0.97 | PTGER2 (0.55) | PTGER2PTGER4PTGER3 | |
| SCHEMBL1057442 | 0.90 | PTGER2 (0.51) | PTGER2PTGER4 | |
| SCHEMBL1052846 | 0.87 | PTGER2 (0.53) | PTGER2PTGER4 | |
| SCHEMBL1055275 | 0.86 | PTGER2 (0.50) | PTGER2PTGER4PTGER3 | |
| SCHEMBL1083098 | 0.86 | PTGER2 (0.50) | PTGER2PTGER4PTGER3 | |
| SCHEMBL1057563 | 0.85 | PTGER2 (0.80) | PTGER2PTGER4PTGER3 | |
| SCHEMBL1057561 | 0.85 | PTGER2 (0.80) | PTGER2PTGER4PTGER3 | |
| SCHEMBL1055565 | 0.85 | PTGER2 (0.80) | PTGER2PTGER4PTGER3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1439837-A1 | PYRAZOLIDINONE COMPOUNDS AS LIGANDS OF THE PROSTAGLANDIN EP2 AND/OR EP4 RECEPTORS | Applied Research Systems ARS Holding N.V. (AN) | 2004-07-28 | — | — | EP | disclosed |
| WO-2003035064-A1 | PYRAZOLIDINONE COMPOUNDS AS LIGANDS OF THE PROSTAGLANDIN EP2 AND/OR EP4 RECEPTORS | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2003-05-01 | — | — | WO | disclosed |